Principal Financial Group Inc Arcturus Therapeutics Holdings Inc. Transaction History

Principal Financial Group Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$24.35 - $44.39 $20,502 - $37,376	-842 Reduced 4.81%	16,674 $406,000
Q1 2024 Apr 29, 2024	BUY	$31.23 - $42.99 $326,478 - $449,417	10,454 Added 148.03%	17,516 $591,000
Q4 2023 Feb 07, 2024	BUY	$17.71 - $32.97 $125,068 - $232,834	7,062 New	7,062 $222,000
Q4 2021 Feb 09, 2022	SELL	$34.2 - $47.56 $175,719 - $244,363	-5,138 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$27.88 - $58.25 $23,196 - $48,464	-832 Reduced 13.94%	5,138 $245,000
Q2 2021 Aug 10, 2021	BUY	$25.79 - $42.11 $14,261 - $23,286	553 Added 10.21%	5,970 $202,000
Q1 2021 May 10, 2021	SELL	$38.75 - $86.92 $201,228 - $451,375	-5,193 Reduced 48.94%	5,417 $224,000
Q4 2020 Feb 08, 2021	BUY	$34.61 - $123.66 $367,212 - $1.31 Million	10,610 New	10,610 $460,000

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $411M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.